| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |